1. Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cells
    Fernando Resende et al, 2018, Oncology Letters CrossRef
  2. Liensinine, a Novel and Food-Derived Compound, Exerts Potent Antihepatoma Efficacy via Inhibiting the Kv10.1 Channel
    Biao Ma et al, 2024, Journal of Agricultural and Food Chemistry CrossRef
  3. Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges
    Alina L. Capatina et al, 2020, Targets of Cancer Diagnosis and Treatment CrossRef
  4. Antibodies Targeting KVPotassium Channels: A Promising Treatment for Cancer
    Ileana Hernandez-Resendiz et al, 2019, Bioelectricity CrossRef
  5. Computational Approaches for Elucidating Protein-Protein Interactions in Cation Channel Signaling
    Baichun Hu et al, 2020, Current Drug Targets CrossRef
  6. Expression and prognosis of GNG5 in lower-grade glioma using public database
    Xiaohui Tan et al, 2022, All Life CrossRef
  7. Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag®
    Simoneide Titze de Almeida et al, 2018, Molecules CrossRef
  8. Potassium Channels in Cancer
    Katrin Ganser et al, 2021, Pharmacology of Potassium Channels CrossRef
  9. Potassium Ion Channels in Glioma: From Basic Knowledge into Therapeutic Applications
    Samar Younes et al, 2023, Membranes CrossRef
  10. Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent
    Bodo Haas et al, 2021, Journal of Cancer Research and Clinical Oncology CrossRef
  11. Electrotherapies for Glioblastoma
    Elise P. W. Jenkins et al, 2021, Advanced Science CrossRef
  12. Ion Channels as Therapeutic Targets in High Grade Gliomas
    Michaela Griffin et al, 2020, Cancers CrossRef
  13. The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells
    Camila Hillesheim Horst et al, 2017, Molecular Medicine Reports CrossRef
  14. Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead
    Rashmi R. Shah et al, 2019, Journal of Clinical Pharmacy and Therapeutics CrossRef
  15. Suppressing nNOS Enzyme by Small-Interfering RNAs Protects SH-SY5Y Cells and Nigral Dopaminergic Neurons from 6-OHDA Injury
    Ricardo Titze-de-Almeida et al, 2019, Neurotoxicity Research CrossRef
  16. A designer peptide against the EAG2–Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma
    Weifan Dong et al, 2023, Nature Cancer CrossRef
  17. Comparison of Elemental Anomalies Following Implantation of Different Cell Lines of Glioblastoma Multiforme in the Rat Brain: A Total Reflection X-ray Fluorescence Spectroscopy Study
    Karolina Planeta et al, 2020, ACS Chemical Neuroscience CrossRef
  18. Bioelectronic medicines: Therapeutic potential and advancements in next-generation cancer therapy
    Arun Kumar Singh et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  19. The Effect of Hydroquinidine on Proliferation and Apoptosis of TMZ-sensitive and -resistant GBM Cells
    Turan Demircan et al, 2023, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  20. Potassium channels and their role in glioma: A mini review
    Jia Liu et al, 2019, Molecular Membrane Biology CrossRef
  21. Voltage-Gated Potassium Channels as Regulators of Cell Death
    Magdalena Bachmann et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
  22. Potassium Channels as a Target for Cancer Therapy: Current Perspectives
    Leandro Zúñiga et al, 2022, OncoTargets and Therapy CrossRef
  23. Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy
    Anna Choromańska et al, 2021, Molecules CrossRef
  24. Glioblastoma quo vadis : Will migration and invasiveness reemerge as therapeutic targets?
    Florence Lefranc et al, 2018, Cancer Treatment Reviews CrossRef
  25. Toward Hijacking Bioelectricity in Cancer to Develop New Bioelectronic Medicine
    Andie J. Robinson et al, 2021, Advanced Therapeutics CrossRef
  26. Overcoming challenges of HERG potassium channel liability through rational design: Eag1 inhibitors for cancer treatment
    Žan Toplak et al, 2022, Medicinal Research Reviews CrossRef
  27. Potassium Ion Channels in Malignant Central Nervous System Cancers
    Yasmin Boyle et al, 2022, Cancers CrossRef
  28. The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market
    Ricardo Titze-de-Almeida et al, 2017, Pharmaceutical Research CrossRef
  29. Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma
    Filiz Senbabaoglu et al, 2020, Frontiers in Neuroscience CrossRef